Multiple Assemblies exist for SMTL entry 5w5o
Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases.;
X-RAY DIFFRACTION
2.89 Å
| |
| |
| |
| |
| |
| |
| |
|